1. Discovery of IL-18 As a Novel Secreted Protein Contributing to Doxorubicin Resistance by Comparative Secretome Analysis of MCF-7 and MCF-7/Dox
   Ling Yao et al, 2011, PLoS ONE CrossRef
2. Activation of IFN/STAT1 signalling predicts response to chemotherapy in oestrogen receptor-negative breast cancer
   Marie-Emmanuelle Legrier et al, 2016, British Journal of Cancer CrossRef
3. The Value of a Tumor Bank in the Development of Cancer Research in Brazil: 13 Years of Experience at the A C Camargo Hospital
   Antonio Hugo Jose Froes Marques Campos et al, 2012, Biopreservation and Biobanking CrossRef
4. Gene trio signatures as molecular markers to predict response to doxorubicin cyclophosphamide neoadjuvant chemotherapy in breast cancerpatients
   M.C. Barros Filho et al, 2010, Brazilian Journal of Medical and Biological Research CrossRef
5. Procurement of Human Tissues for Research Banking in the Surgical Pathology Laboratory: Prioritization Practices at Washington University Medical Center
   Sandra A. McDonald et al, 2011, Biopreservation and Biobanking CrossRef
6. DDX5/p68 associated lncRNA LOC284454 is differentially expressed in human cancers and modulates gene expression
   Monalisa Das et al, 2018, RNA Biology CrossRef
7. The Application of Chemometrics for Efficiency Enhancement and Toxicity Reduction in Cancer Treatment with Combined Therapy
   Ke Qian et al, 2021, Current Drug Delivery CrossRef
8. Future Role of Molecular Profiling in Small Breast Samples and Personalised Medicine
   Sarah Yen Mi Sim et al, 2016, A Comprehensive Guide to Core Needle Biopsies of the Breast CrossRef
9. Differential Roles for DUSP Family Members in Epithelial-to-Mesenchymal Transition and Cancer Stem Cell Regulation in Breast Cancer
   Tara Boulding et al, 2016, PLOS ONE CrossRef
10. Perfil transcricional e resposta à quimioterapia neoadjuvante em câncer de mama
    Maria Aparecida Azevedo Koike Folgueira et al, 2011, Revista da Associação Médica Brasileira CrossRef
11. Upregulation of Prolactin Receptor Expression and Activation of Prolactin Signaling in an Aggressive Triple-Negative Breast Carcinoma During Pregnancy: A Case Report
    Nikolay Popnikolov et al, 2020, Clinical Breast Cancer CrossRef
12. Alogliptin attenuates cyclophosphamide-induced nephrotoxicity: a novel therapeutic approach through modulating MAP3K/JNK/SMAD3 signaling cascade
    Rania M. Salama et al, 2022, Drug and Chemical Toxicology CrossRef
13. Transcriptional profile and response to neoadjuvant chemotherapy in breast cancer
    Maria Aparecida Azevedo Koike Folgueira et al, 2011, Revista da Associação Médica Brasileira (English Edition) CrossRef
14. A proteomic analysis of chemoresistance development via sequential treatment with doxorubicin reveals novel players in MCF‑7 breast cancer cells
    Ann‑Katrin Sommer et al, 2018, International Journal of Molecular Medicine CrossRef
15. Molecular Profiles of Pre- and Postoperative Breast Cancer Tumours Reveal Differentially Expressed Genes
    Margit L. H. Riis et al, 2012, ISRN Oncology CrossRef
16. Future Role of Molecular Profiling in Small Breast Samples and Personalised Medicine
    Samuel Y. F. Foong et al, 2022, A Comprehensive Guide to Core Needle Biopsies of the Breast CrossRef
17. Transcriptional profile and response to neoadjuvant chemotherapy in breast cancer
    Maria Aparecida Azevedo Koike Folgueira et al, 2011, Revista da Associação Médica Brasileira CrossRef
18. Receptor Status Change From Primary to Residual Breast Cancer After Neoadjuvant Chemotherapy and Analysis of Survival Outcomes
    Napa Parinyanitikul et al, 2015, Clinical Breast Cancer CrossRef
19. Tumor Evolution Inferred by Patterns of microRNA Expression through the Course of Disease, Therapy, and Recurrence in Breast Cancer
    Maya Dadiani et al, 2016, Clinical Cancer Research CrossRef
20. Dual-specificity phosphatases: therapeutic targets in cancer therapy resistance
    Zahra Zandi et al, 2022, Journal of Cancer Research and Clinical Oncology CrossRef
21. Distinct homologous recombination gene expression profiles after neoadjuvant chemotherapy associated with clinical outcome in patients with ovarian cancer
    Roy Kessous et al, 2018, Gynecologic Oncology CrossRef